Prescription Drug Supply Chain Pricing Transparency Act
Sponsor
Full profile: /officials/B001267
Source: Congress.gov · FEC
Cosponsors (1)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Plain-English Summary
This bill would require drug manufacturers, wholesalers, and pharmacy benefit managers to disclose detailed pricing information throughout the prescription drug supply chain, making it easier to see how much money each company makes from drug sales. By pulling back the curtain on these hidden markups and fees, the bill aims to help patients, insurers, and policymakers understand why prescription drugs cost so much and identify where prices are being inflated. The transparency could put pressure on companies to justify high prices and potentially help lawmakers design policies to lower drug costs.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Affected Industries
Industries and interest groups with a stake in how this bill is resolved. Compare with each member's outside-money backers on their finance page.
Why this matters: Look up any member who voted on this bill and check their finance page — do the industries listed above match the groups funding their campaigns? That's the kind of connection this tool is built to help you find.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S4589OPEN ActReferred to Committee · 2026-05-20
- S4590KIDS ActReferred to Committee · 2026-05-20
- S4596TRUST ActReferred to Committee · 2026-05-20
- S4575SMART Community Policing ActReferred to Committee · 2026-05-19